The Digital Therapeutics market is expected to grow at CAGR of 20.7% to reach USD 8.92 billion by 2025.

Digital therapeutics (a subset of digital health) is an evidence-based treatment method that can be offered through phones, apps, sensors, and computers. Such a treatment method is considered to be an effective alternative strategy to traditional healthcare for the management and prevention of mental health conditions and chronic diseases. Favourable government initiatives coupled with new product approvals augment the market growth significantly. For instance, in the U.S. FDA approval of Oleena (July 2019), the first oncology digital therapeutic from Voluntis will catch the attention of investors. With an estimated over 1.7 million new cancer cases diagnosed yearly in the U.S., approval of this product will open up new opportunities for cancer patients for better treatment outcomes.

Other associated benefits of digital therapeutics such as cost-effectiveness and significant improvement in the patient outcome will support industry development. On the flip side, lack of proper reimbursements by private and public health insurance providers will limit the widespread use of digital therapeutics, hampering the market growth.

Browse 150 Tables and 90 Figures spread through over 150 Pages and in-depth TOC on “ Digital Therapeutics Market, By Application (Diabetes, Cardiovascular Disorders, Central Nervous System Disease, Smoking Cessation, Obesity, and Respiratory Disease), By End Use (Providers, Patients, Employers, and Payers), and Geography (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa) – Analysis, Share, Trends, Size, & Forecast from 2019 – 2025“
Request report sample here 

KEY HIGHLIGHTS

• Application-wise, the market is segmented as central nervous system disease, smoking cessation, diabetes, cardiovascular disorders, obesity, respiratory disease, and others.
• Cost-effective digital therapeutic solutions may win significant industry share in areas such as addiction, depression, obesity, and smoking cessation
• The end-user segment is classified as employers, payers, providers, patients, and others. The demand for digital therapeutics is anticipated to grow with promising CAGR across the end-user segments as payers and insurers use data and analytics to manage medical costs and help patients to receive proper treatment.
• In terms of types, the industry is broadly categorized as Hardware and Software. In terms of distribution channel, the industry is categorized into Business-to-consumer (B2C) (caregivers, and patients), and Business-to-business (B2B) Employers (healthcare, and providers)
• Companies namely Proteus Digital Health, Inc., Omada Health, Inc., 2Morrow, Inc., Propeller Health, Canary Health, Inc., WellDoc, Inc., Mango Health, Inc., and Twine health are actively operating in this market
• The worldwide digital therapeutic industry is booming and companies are revealing transformative new approaches to increase market share.
• Likewise, recently in January 2019, ResMed acquired Propeller Health, a U.S. based digital health innovator. this will help the company to strengthen its digital platform to better serve patients across the chronic respiratory disease spectrum.

The scope of this report covers the market by its major segments, which include as follows:

KEY MANUFACTURERS

• Omada Health, Inc.
• Propeller Health
• Proteus Digital Health, Inc.
• 2Morrow, Inc.
• WellDoc, Inc.
• Canary Health, Inc.
• Twine health
• Mango Health, Inc.

MARKET, BY APPLICATION

• Diabetes
• Cardiovascular Disorders
• Central Nervous System Disease
• Smoking Cessation
• Obesity
• Respiratory Disease
• Others

MARKET, BY END USE

• Providers
• Patients
• Employers
• Payers
• Others

MARKET, BY TYPES

• Hardware
• Software

MARKET, BY USER

• Care
• Prevention

MARKET, BY SALES CHANNEL

• Business-To-Business (B2B) Employers
  • Healthcare
  • Providers
• Business-to-consumer (B2C) Employers
  • Caregivers
  • Patients

MARKET, BY REGION

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA